126 related articles for article (PubMed ID: 29424918)
1. Highly expressed long non-coding RNA DUXAP10 promotes proliferation of ovarian cancer.
Zhang Q; Wang WW; Xu TH; Xu ZF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):314-321. PubMed ID: 29424918
[TBL] [Abstract][Full Text] [Related]
2. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
Yao N; Yu L; Zhu B; Gan HY; Guo BQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8127-8134. PubMed ID: 30556850
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA DUXAP10 promotes the proliferation, migration, and inhibits apoptosis of prostate cancer cells.
Wang XF; Chen J; Gong YB; Qin YC; Wang L; Li NC
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3699-3708. PubMed ID: 31114994
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA SNHG16 promotes cell growth and metastasis in ovarian cancer.
Yang XS; Wang GX; Luo L
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):616-622. PubMed ID: 29461589
[TBL] [Abstract][Full Text] [Related]
5. Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer.
Zhao LP; Li RH; Han DM; Zhang XQ; Nian GX; Wu MX; Feng Y; Zhang L; Sun ZG
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5353-5360. PubMed ID: 29243775
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin suppresses tumor proliferation by inhibiting autophagy in ovarian cancer via long non-coding RNA RP11-135L22.1.
Zou SH; Du X; Sun FD; Wang PC; Li M
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):928-935. PubMed ID: 29509240
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
Hong L; Chen W; Wu D; Wang Y
Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
[TBL] [Abstract][Full Text] [Related]
8. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
Ma SY; Wei P; Qu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of long non-coding RNA DUXAP10 inhibits proliferation, migration, and invasion of renal cell carcinoma.
Chen J; Wang XF; Qin YC; Gong YB; Wang L; Li NC
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11041-11051. PubMed ID: 33215419
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical significance of long-non-coding RNA GHET1 in pancreatic cancer.
Zhou HY; Zhu H; Wu XY; Chen XD; Qiao ZG; Ling X; Yao XM; Tang JH
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5081-5088. PubMed ID: 29228419
[TBL] [Abstract][Full Text] [Related]
11. LncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290.
Lai XJ; Cheng HF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):322-328. PubMed ID: 29424889
[TBL] [Abstract][Full Text] [Related]
12. High expression of LncRNA CASC15 is a risk factor for gastric cancer prognosis and promote the proliferation of gastric cancer.
Yao XM; Tang JH; Zhu H; Jing Y
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5661-5667. PubMed ID: 29272000
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
14. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
15. A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer.
Jing H; Qu X; Liu L; Xia H
Med Sci Monit; 2018 Jun; 24():4317-4323. PubMed ID: 29935018
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of pseudogene derived from lncRNA DUXAP10 inhibits cell proliferation, migration, invasion, and promotes apoptosis in pancreatic cancer.
Lian Y; Xiao C; Yan C; Chen D; Huang Q; Fan Y; Li Z; Xu H
J Cell Biochem; 2018 Apr; 119(4):3671-3682. PubMed ID: 29286182
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer.
Huang HW; Xie H; Ma X; Zhao F; Gao Y
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4529-4535. PubMed ID: 29131264
[TBL] [Abstract][Full Text] [Related]
19. Long Non-coding RNA
Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT
Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating FOXA1.
Zheng ZJ; Liu Y; Wang HJ; Pang WW; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9282-9289. PubMed ID: 33015769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
